Of 19 RCTs, 2 were of moderate methodologic quality, and 17 were of high methodologic quality.
In many of these trials, the MFR treatment was adjunctive to other treatments, and the potential specific MFR effect could not be determined.
In the reviewed study, MFR was demonstrated to be equal to or more effective than sham, conventional, and no treatment for various musculoskeletal and painful conditions. Of 19 studies, 14 were determined to be category 2b evidence (ie, small sample size and no long-term follow-up), with the other 5 as category 1b (ie, none achieved the highest level of 1a). 
